Heparin Sodium in 5% Dextrose Injection, 25000unit/500ml 5 g (Dextrose SOLUTION) 5 G

Heparin Sodium in 5% Dextrose Injection is a combination of heparin and dextrose, used for anticoagulation and fluid replacement. This intravenous solution is designed for medical use under professional supervision.

Strength

5 G

Pack Size

500ML

Manufacturer / TM Owner

B. BRAUN MEDICAL INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Heparin Sodium in 5% Dextrose Injection is primarily used for anticoagulation, helping to prevent blood clots. The dextrose component provides a source of calories and helps maintain fluid balance. This solution is often administered in clinical settings where both anticoagulation and fluid replacement are required.

Side Effects

Common effects of Heparin Sodium in 5% Dextrose Injection may include localized reactions at the injection site, such as redness or swelling. Some individuals might experience systemic effects like changes in blood pressure or heart rate. Always use under medical supervision.

Precautions & Warnings

Heparin Sodium in 5% Dextrose Injection should be handled with care to avoid contamination. It is essential to follow proper storage and administration guidelines. Patients with certain medical conditions or allergies should consult a healthcare provider before use.

Avoid Interactions

Heparin Sodium in 5% Dextrose Injection may interact with other medications, particularly those affecting blood clotting. It is important to inform healthcare providers about all current medications to avoid potential interactions. Always use as directed by a medical professional.

Frequently Asked Questions

It is used for anticoagulation and fluid replacement in clinical settings.

This solution is administered intravenously under medical supervision.

Common effects may include localized reactions at the injection site and systemic effects like changes in blood pressure.

Patients with certain medical conditions or allergies should consult a healthcare provider before use.

Yes, it may interact with medications affecting blood clotting, so inform healthcare providers about all current medications.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.